Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

American Programme Review Group

Chairman
Jean-Francois Vely
Rue Theodule No 1
Port au Prince
Haiti






Tel:+ 404 4997
email: joeve_44@yahoo.fr

WHO Focal Point
Dr Steve Ault
Regional Advisor in Communicable Diseases (Parasitic Diseases)
Communicable Diseases Unit (CD)
Room 714, DPC
Regional Office for the Americas/Pan American Sanitary Bureau (AMRO/PAHO)
525, 23rd Street NW
Washington DC
USA

Tel: +1 (202) 974 3896
Fax: +1 (202) 974 3656 or +1 (202) 974 3331
email: aultstev@paho.org


Immuno-chromatographic ICT cards have enabled the countries in the Region to re-assess the epidemiological situation of LF. Current evidence strongly suggests that Suriname, Trinidad & Tobago and Costa Rica have eliminated transmission. Belém and Maceio, two of three foci in Brazil, also have apparently interrupted transmission recently. Guyana launched a programme based on the DEC-fortified salt regimen, and continues efforts to scale it up.

The potential of integrating control programs into other ongoing public health initiatives in the Region is good, as are the prospects of implementing the programs in a cost-effective, socially responsible manner through links with other programs. There has been significant progress in re-assessing the status of infection and disease in the seven endemic or formerly-endemic countries and this important knowledge will allow the Region to redefine the at-risk population, the treatment targets and the implementation units (IU).

Work remains to be done to assess the scale of the problems of disability and to develop an appropriate response to address it. Some of the programs face obstacles, including the lack of both human and financial resources and, at times, political commitment. Thus, the Global Alliance is confronted with the challenge of conducting intensive advocacy among those capable of effective action, including the Ministries of Health, the NGDOs, the bilateral agencies and the United Nations system.

Among the biggest challenges are the need to scale-up efforts in those countries where mass distribution activities are on-going. Among the most important assets sustaining the regional LF elimination efforts are the partnerships and alliances that have evolved among the countries, the international community, the private sector and non governmental organizations (NGO). Our regional initiative must quickly consolidate a rational disability prevention and rehabilitation program in collaboration with our partners and sponsors.

 

© Global Alliance to Eliminate Lymphatic Filariasis